FDA Clearance Tracker · P040020-S014
ACRYSOF IQ RESTOR IOLS 3.0 AND 4.0 D ADD POWERS
Last checked: Nov 20, 2026Latest source record: Aug 20, 2009 (this decision)Source: openFDAMethods & limitations
Decided
Aug 20, 2009
Approved
Time to decision
164 days
Received Mar 9, 2009. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P040020-S014
- Device name
- ACRYSOF IQ RESTOR IOLS 3.0 AND 4.0 D ADD POWERS
- Applicant
- Alcon Research, Ltd.
- Applicant location
- Fort Worth, TX
- Received
- Mar 9, 2009
- Decided
- Aug 20, 2009
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P040020
Device type
- Device type
- Lens, multifocal intraocular (MFK)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR CHANGES TO THE LABELING,REVISING THE DIRECTIONS FOR USE (DFU) AND PATIENT BROCHURE WITH UPDATED SIX-MONTHFOLLOW UP DATA FROM THE CLINICAL INVESTIGATION FOR THE LENSES. THE DEVICES, AS MODIFIEDWILL BE MARKETED UNDER THE TRADE NAME ACRYSOF IQ RESTOR INTRAOCULAR LENSES(IOLS) +3.0 D (MODELS: SN6AD1 AND MN6AD1) AND +4.0 D (MODELS: SN6AD3 ANDMN6AD3) ADD POWERS AND IS INDICATED FOR PRIMARY IMPLANTATION FOR THE VISUAL CORRECTIONOF APHAKIA SECONDARY TO REMOVAL OF A CATARACTOUS LENS IN ADULT PATIENTS WITH OR WITHOUTPRESBYOPIA, WHO DESIRE NEAR, INTERMEDIATE AND DISTANCE VISION WITH INCREASED SPECTACLEINDEPENDENCE. THE LENS IS INTENDED TO BE PLACED IN THE CAPSULAR BAG.
Source documents
Other decisions for Alcon Research, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- AcrySof IQ PanOptix Trifocal Intraocular Lens and AcrySof IQ PanOptix Toric Trifocal Intraocular LensPMA supplement
P040020-S087 · Decided Aug 26, 2019 · 207 days after receipt · Panel Track
Device type: Lens, multifocal intraocular (MFK) · Ophthalmology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.